897 — Wai Yuen Tong Medicine Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual income statement for Wai Yuen Tong Medicine Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.

	R2020 March 31st	2021 March 31st	2022 March 31st	R2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	621	1,109	1,391	724	784
Cost of Revenue
Gross Profit	282	439	570	342	395
Selling / General / Administrative Expenses
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	128	1,309	1,345	703	759
Operating Profit	493	-200	46.8	20.7	24.6
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	455	-303	-47.3	-5.91	-13.6
Provision for Income Taxes
Net Income After Taxes	438	-451	-87.8	7.41	-7.27
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	439	-376	-109	-20.5	-15.4
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	439	-376	-109	-20.5	-15.4
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.079	-0.193	-0.114	-0.002	-0.001
Dividends per Share
Special Dividends per Share